

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine deamination (GO:0009972) | 6.55189724 |
| 2 | cytidine metabolic process (GO:0046087) | 6.55189724 |
| 3 | cytidine catabolic process (GO:0006216) | 6.55189724 |
| 4 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.98774867 |
| 5 | cellular response to interleukin-15 (GO:0071350) | 5.84696680 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.82609814 |
| 7 | DNA deamination (GO:0045006) | 5.81751928 |
| 8 | positive T cell selection (GO:0043368) | 5.73432272 |
| 9 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.65195784 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.59470288 |
| 11 | cellular response to type I interferon (GO:0071357) | 5.41695941 |
| 12 | type I interferon signaling pathway (GO:0060337) | 5.41695941 |
| 13 | response to type I interferon (GO:0034340) | 5.39894188 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.33756445 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.33756445 |
| 16 | response to interleukin-15 (GO:0070672) | 5.31239888 |
| 17 | positive regulation of interferon-alpha production (GO:0032727) | 5.25586136 |
| 18 | regulation of regulatory T cell differentiation (GO:0045589) | 4.99702847 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 4.94584661 |
| 20 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.94483193 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.92297074 |
| 22 | activated T cell proliferation (GO:0050798) | 4.90252973 |
| 23 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.89134228 |
| 24 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.89134228 |
| 25 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.69233397 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 4.66020963 |
| 27 | thymic T cell selection (GO:0045061) | 4.64811146 |
| 28 | T cell selection (GO:0045058) | 4.64330820 |
| 29 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.50250838 |
| 30 | cellular response to exogenous dsRNA (GO:0071360) | 4.46435996 |
| 31 | cellular response to interferon-alpha (GO:0035457) | 4.38369298 |
| 32 | T cell migration (GO:0072678) | 4.38011464 |
| 33 | cellular response to interferon-beta (GO:0035458) | 4.36741499 |
| 34 | immunoglobulin mediated immune response (GO:0016064) | 4.33262355 |
| 35 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.29423518 |
| 36 | positive regulation by symbiont of host defense response (GO:0052509) | 4.17389055 |
| 37 | modulation by symbiont of host defense response (GO:0052031) | 4.17389055 |
| 38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.17389055 |
| 39 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.17389055 |
| 40 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.17389055 |
| 41 | modulation by symbiont of host immune response (GO:0052553) | 4.17389055 |
| 42 | positive regulation of tolerance induction (GO:0002645) | 4.16770278 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.14721218 |
| 44 | interferon-gamma production (GO:0032609) | 4.10260669 |
| 45 | positive regulation of cell killing (GO:0031343) | 4.10099740 |
| 46 | response to interferon-alpha (GO:0035455) | 4.10030404 |
| 47 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.08682044 |
| 48 | cellular response to zinc ion (GO:0071294) | 4.08666724 |
| 49 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.02827367 |
| 50 | defense response to protozoan (GO:0042832) | 4.02698642 |
| 51 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.01888974 |
| 52 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.01657450 |
| 53 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.99638314 |
| 54 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.99213810 |
| 55 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.98869028 |
| 56 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.98041504 |
| 57 | negative regulation of T cell apoptotic process (GO:0070233) | 3.97831783 |
| 58 | T cell receptor signaling pathway (GO:0050852) | 3.97657069 |
| 59 | regulation of cell killing (GO:0031341) | 3.96739321 |
| 60 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.94279490 |
| 61 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.92766070 |
| 62 | neutrophil activation (GO:0042119) | 3.91270976 |
| 63 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.90575747 |
| 64 | natural killer cell mediated immunity (GO:0002228) | 3.90575747 |
| 65 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.90178116 |
| 66 | positive regulation of type 2 immune response (GO:0002830) | 3.89087446 |
| 67 | regulation of RIG-I signaling pathway (GO:0039535) | 3.88097555 |
| 68 | granulocyte activation (GO:0036230) | 3.87348192 |
| 69 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.86812272 |
| 70 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.85944499 |
| 71 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.84167632 |
| 72 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.82648316 |
| 73 | negative regulation of viral genome replication (GO:0045071) | 3.79995550 |
| 74 | regulation of activation of Janus kinase activity (GO:0010533) | 3.74363192 |
| 75 | regulation of tolerance induction (GO:0002643) | 3.73445314 |
| 76 | response to peptidoglycan (GO:0032494) | 3.72720985 |
| 77 | negative regulation by host of viral transcription (GO:0043922) | 3.71781398 |
| 78 | positive regulation of interferon-beta production (GO:0032728) | 3.70575531 |
| 79 | respiratory burst (GO:0045730) | 3.68071084 |
| 80 | B cell receptor signaling pathway (GO:0050853) | 3.65861396 |
| 81 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.65710766 |
| 82 | positive regulation of interleukin-12 production (GO:0032735) | 3.65002457 |
| 83 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.64253481 |
| 84 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.59119131 |
| 85 | T cell costimulation (GO:0031295) | 3.57391597 |
| 86 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.57265864 |
| 87 | negative thymic T cell selection (GO:0045060) | 3.56625124 |
| 88 | cellular response to virus (GO:0098586) | 3.55728359 |
| 89 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.53633459 |
| 90 | lymphocyte costimulation (GO:0031294) | 3.53103199 |
| 91 | response to protozoan (GO:0001562) | 3.50782037 |
| 92 | negative regulation of T cell mediated immunity (GO:0002710) | 3.48814280 |
| 93 | negative T cell selection (GO:0043383) | 3.48605547 |
| 94 | response to interferon-beta (GO:0035456) | 3.47260895 |
| 95 | T-helper 1 type immune response (GO:0042088) | 3.47060419 |
| 96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.46832462 |
| 97 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.46382759 |
| 98 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.45918147 |
| 99 | positive regulation of antigen processing and presentation (GO:0002579) | 3.44487453 |
| 100 | B cell mediated immunity (GO:0019724) | 3.43829915 |
| 101 | positive regulation of T cell cytokine production (GO:0002726) | 3.43365467 |
| 102 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.41779158 |
| 103 | negative regulation of cell killing (GO:0031342) | 3.41779158 |
| 104 | natural killer cell activation (GO:0030101) | 3.40997403 |
| 105 | leukocyte aggregation (GO:0070486) | 3.40867881 |
| 106 | macrophage activation involved in immune response (GO:0002281) | 3.37648675 |
| 107 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.36120288 |
| 108 | dendritic cell chemotaxis (GO:0002407) | 3.35574669 |
| 109 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.34705175 |
| 110 | natural killer cell differentiation (GO:0001779) | 3.33945225 |
| 111 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.33706529 |
| 112 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.33466785 |
| 113 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.32926820 |
| 114 | cellular response to interferon-gamma (GO:0071346) | 3.32799265 |
| 115 | actin nucleation (GO:0045010) | 3.32404592 |
| 116 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.30405687 |
| 117 | positive regulation of defense response to virus by host (GO:0002230) | 3.29322470 |
| 118 | regulation of chronic inflammatory response (GO:0002676) | 3.29004607 |
| 119 | positive regulation of granulocyte differentiation (GO:0030854) | 3.27784301 |
| 120 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.27522134 |
| 121 | regulation of gamma-delta T cell activation (GO:0046643) | 3.27241521 |
| 122 | positive regulation of T cell chemotaxis (GO:0010820) | 3.26604677 |
| 123 | regulation of T cell chemotaxis (GO:0010819) | 3.26604677 |
| 124 | cellular defense response (GO:0006968) | 3.25113970 |
| 125 | myeloid dendritic cell activation (GO:0001773) | 3.23580584 |
| 126 | myeloid dendritic cell differentiation (GO:0043011) | 3.23388232 |
| 127 | negative regulation of B cell proliferation (GO:0030889) | 3.22420154 |
| 128 | mast cell activation (GO:0045576) | 3.20879561 |
| 129 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.20386849 |
| 130 | myeloid cell activation involved in immune response (GO:0002275) | 3.20322325 |
| 131 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.19422305 |
| 132 | dendritic cell migration (GO:0036336) | 3.18868909 |
| 133 | positive regulation of interleukin-17 production (GO:0032740) | 3.18584724 |
| 134 | defense response to virus (GO:0051607) | 3.18507083 |
| 135 | regulation of B cell differentiation (GO:0045577) | 3.17749252 |
| 136 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.17482416 |
| 137 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.15804708 |
| 138 | response to host immune response (GO:0052572) | 3.12206375 |
| 139 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.12206375 |
| 140 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11756506 |
| 141 | NIK/NF-kappaB signaling (GO:0038061) | 3.11676985 |
| 142 | positive regulation of interleukin-2 production (GO:0032743) | 3.10322784 |
| 143 | regulation of calcium-mediated signaling (GO:0050848) | 3.08868765 |
| 144 | positive regulation of isotype switching (GO:0045830) | 3.07305883 |
| 145 | lymphocyte chemotaxis (GO:0048247) | 3.07175791 |
| 146 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.05126455 |
| 147 | negative regulation of interleukin-17 production (GO:0032700) | 3.04910164 |
| 148 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.04778809 |
| 149 | regulation of T cell tolerance induction (GO:0002664) | 3.04445670 |
| 150 | positive thymic T cell selection (GO:0045059) | 3.04165374 |
| 151 | regulation of antigen processing and presentation (GO:0002577) | 3.02117851 |
| 152 | cytolysis (GO:0019835) | 3.01777400 |
| 153 | leukocyte mediated cytotoxicity (GO:0001909) | 3.01621106 |
| 154 | regulation of defense response to virus by host (GO:0050691) | 3.01030034 |
| 155 | positive regulation of response to biotic stimulus (GO:0002833) | 3.00924931 |
| 156 | positive regulation of B cell differentiation (GO:0045579) | 3.00819373 |
| 157 | regulation of interleukin-12 production (GO:0032655) | 3.00633236 |
| 158 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.00424962 |
| 159 | positive regulation of lymphocyte migration (GO:2000403) | 3.00096537 |
| 160 | chemokine-mediated signaling pathway (GO:0070098) | 2.98676941 |
| 161 | positive regulation of interleukin-4 production (GO:0032753) | 2.98278529 |
| 162 | eosinophil chemotaxis (GO:0048245) | 2.97737349 |
| 163 | tolerance induction (GO:0002507) | 2.97177455 |
| 164 | positive regulation of T cell mediated immunity (GO:0002711) | 2.96349325 |
| 165 | regulation of T cell apoptotic process (GO:0070232) | 2.94117983 |
| 166 | lymphocyte migration (GO:0072676) | 2.91797931 |
| 167 | T cell differentiation (GO:0030217) | 2.91156687 |
| 168 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.90459689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.66062302 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.95873640 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.93394971 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.81031167 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.75381604 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.10685171 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.84960542 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.69498533 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.49638897 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.35239002 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.33217757 |
| 12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.29189394 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.23011507 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22794500 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.58227470 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.44044780 |
| 17 | * MYB_26560356_Chip-Seq_TH2_Human | 2.39731683 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.29450744 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.24074874 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.22129675 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.16456040 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.11156486 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.10585638 |
| 24 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.08199880 |
| 25 | * MYB_26560356_Chip-Seq_TH1_Human | 1.99942343 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.92250524 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.85299286 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79546627 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75783539 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.74845598 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.69155994 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.68582388 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68366729 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65529830 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59747037 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.58885765 |
| 37 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.57770368 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.56983008 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56955347 |
| 40 | MYC_22102868_ChIP-Seq_BL_Human | 1.55162029 |
| 41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.53212065 |
| 42 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53002198 |
| 43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50233676 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48510561 |
| 45 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.47589970 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46134284 |
| 47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45654933 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44782943 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39116057 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38768809 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38276365 |
| 52 | GATA3_26560356_Chip-Seq_TH2_Human | 1.37751029 |
| 53 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.29897133 |
| 54 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.28190501 |
| 55 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.27818615 |
| 56 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23545000 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.23119642 |
| 58 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22322912 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21934886 |
| 60 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21232636 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20463464 |
| 62 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19869491 |
| 63 | VDR_22108803_ChIP-Seq_LS180_Human | 1.18573186 |
| 64 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.17665325 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.16564052 |
| 66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15818747 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14993415 |
| 68 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14937631 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13739838 |
| 70 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.13412709 |
| 71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11802206 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10083815 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10019281 |
| 74 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08948281 |
| 75 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.06521523 |
| 76 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04006420 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03608254 |
| 78 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.01284255 |
| 79 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99873784 |
| 80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97984999 |
| 81 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97791342 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97522888 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97288016 |
| 84 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97102844 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97074376 |
| 86 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95489653 |
| 87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94484368 |
| 88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.93804153 |
| 89 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93688798 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93340268 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92988791 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92954540 |
| 93 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92592442 |
| 94 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91869100 |
| 95 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.91730639 |
| 96 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.91663943 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90637884 |
| 98 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.89269781 |
| 99 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87529154 |
| 100 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86522742 |
| 101 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.86184731 |
| 102 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86177187 |
| 103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85157694 |
| 104 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.85040952 |
| 105 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.85030232 |
| 106 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.84559065 |
| 107 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84213579 |
| 108 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.83313061 |
| 109 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.83281376 |
| 110 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.82926813 |
| 111 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.81588027 |
| 112 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.81588027 |
| 113 | * TP53_22573176_ChIP-Seq_HFKS_Human | 0.81289280 |
| 114 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80982203 |
| 115 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.80511365 |
| 116 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79653896 |
| 117 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.78608859 |
| 118 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.78155769 |
| 119 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.77082376 |
| 120 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76974227 |
| 121 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.76853069 |
| 122 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.76344651 |
| 123 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76195195 |
| 124 | AR_20517297_ChIP-Seq_VCAP_Human | 0.75372899 |
| 125 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75316588 |
| 126 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.75189939 |
| 127 | * P300_27268052_Chip-Seq_Bcells_Human | 0.72575963 |
| 128 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.71762843 |
| 129 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71257707 |
| 130 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.68992242 |
| 131 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.68650278 |
| 132 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.68103057 |
| 133 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67905691 |
| 134 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.64137467 |
| 135 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.62411949 |
| 136 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.61045754 |
| 137 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.59749411 |
| 138 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.59336771 |
| 139 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.58791754 |
| 140 | GATA3_26560356_Chip-Seq_TH1_Human | 0.58229521 |
| 141 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.57677835 |
| 142 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.57406336 |
| 143 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.57205268 |
| 144 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.51814574 |
| 145 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.51715830 |
| 146 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.50664422 |
| 147 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.49849696 |
| 148 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.48806662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.57370310 |
| 2 | MP0009785_altered_susceptibility_to | 4.13162161 |
| 3 | MP0005671_abnormal_response_to | 3.88539711 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.76566979 |
| 5 | MP0000685_abnormal_immune_system | 3.72086800 |
| 6 | MP0005387_immune_system_phenotype | 3.67931097 |
| 7 | MP0001790_abnormal_immune_system | 3.67931097 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.56364183 |
| 9 | MP0001800_abnormal_humoral_immune | 3.43414413 |
| 10 | MP0003436_decreased_susceptibility_to | 3.40330473 |
| 11 | MP0005025_abnormal_response_to | 3.27123618 |
| 12 | MP0006082_CNS_inflammation | 3.14632270 |
| 13 | MP0002452_abnormal_antigen_presenting | 3.12156868 |
| 14 | MP0002723_abnormal_immune_serum | 3.03964559 |
| 15 | MP0003303_peritoneal_inflammation | 2.94968961 |
| 16 | MP0002419_abnormal_innate_immunity | 2.87780914 |
| 17 | MP0003724_increased_susceptibility_to | 2.83644619 |
| 18 | MP0001819_abnormal_immune_cell | 2.78197556 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.75211111 |
| 20 | MP0004510_myositis | 2.33632150 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.32740173 |
| 22 | MP0002006_tumorigenesis | 2.30381338 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.27432295 |
| 24 | MP0002398_abnormal_bone_marrow | 2.26223594 |
| 25 | MP0000716_abnormal_immune_system | 2.20851524 |
| 26 | MP0001845_abnormal_inflammatory_respons | 1.96507024 |
| 27 | MP0004947_skin_inflammation | 1.96264126 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.95755411 |
| 29 | MP0002405_respiratory_system_inflammati | 1.94341779 |
| 30 | MP0001853_heart_inflammation | 1.86583359 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.77417993 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.77029964 |
| 33 | MP0002429_abnormal_blood_cell | 1.75905147 |
| 34 | MP0004381_abnormal_hair_follicle | 1.75303240 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.75049201 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.71228780 |
| 37 | MP0002722_abnormal_immune_system | 1.67653449 |
| 38 | MP0008469_abnormal_protein_level | 1.66805328 |
| 39 | MP0009764_decreased_sensitivity_to | 1.62813314 |
| 40 | MP0005075_abnormal_melanosome_morpholog | 1.59992254 |
| 41 | MP0003448_altered_tumor_morphology | 1.57985832 |
| 42 | MP0005310_abnormal_salivary_gland | 1.55933967 |
| 43 | MP0003787_abnormal_imprinting | 1.39604901 |
| 44 | MP0002638_abnormal_pupillary_reflex | 1.37404908 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.32298181 |
| 46 | MP0000858_altered_metastatic_potential | 1.30664071 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.24870556 |
| 48 | MP0002009_preneoplasia | 1.20937786 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.19478933 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.19478933 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.10973528 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.08534296 |
| 53 | MP0004808_abnormal_hematopoietic_stem | 1.07939624 |
| 54 | MP0001873_stomach_inflammation | 1.07746813 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.07259338 |
| 56 | MP0001919_abnormal_reproductive_system | 1.05745430 |
| 57 | MP0010307_abnormal_tumor_latency | 1.04092394 |
| 58 | MP0002396_abnormal_hematopoietic_system | 1.03800469 |
| 59 | MP0008877_abnormal_DNA_methylation | 1.02980603 |
| 60 | MP0002102_abnormal_ear_morphology | 1.01449614 |
| 61 | MP0008057_abnormal_DNA_replication | 1.01359668 |
| 62 | MP0002933_joint_inflammation | 1.00444109 |
| 63 | MP0009278_abnormal_bone_marrow | 1.00260317 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.00007173 |
| 65 | MP0005645_abnormal_hypothalamus_physiol | 0.99876154 |
| 66 | MP0003075_altered_response_to | 0.99183571 |
| 67 | MP0009763_increased_sensitivity_to | 0.98575297 |
| 68 | MP0003866_abnormal_defecation | 0.98569476 |
| 69 | MP0003646_muscle_fatigue | 0.97692135 |
| 70 | MP0000343_altered_response_to | 0.95487944 |
| 71 | MP0001986_abnormal_taste_sensitivity | 0.94028978 |
| 72 | MP0000372_irregular_coat_pigmentation | 0.93086581 |
| 73 | MP0000569_abnormal_digit_pigmentation | 0.92128517 |
| 74 | MP0005166_decreased_susceptibility_to | 0.87120840 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 0.86799938 |
| 76 | MP0004142_abnormal_muscle_tone | 0.83875287 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 0.82507692 |
| 78 | MP0004130_abnormal_muscle_cell | 0.82364896 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 0.82018093 |
| 80 | MP0001348_abnormal_lacrimal_gland | 0.79239268 |
| 81 | MP0002163_abnormal_gland_morphology | 0.78391885 |
| 82 | MP0003045_fibrosis | 0.77262879 |
| 83 | MP0003186_abnormal_redox_activity | 0.76594891 |
| 84 | MP0002019_abnormal_tumor_incidence | 0.76011784 |
| 85 | MP0008872_abnormal_physiological_respon | 0.75351253 |
| 86 | MP0004883_abnormal_blood_vessel | 0.74163728 |
| 87 | MP0000490_abnormal_crypts_of | 0.71022520 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.69812059 |
| 89 | MP0000604_amyloidosis | 0.69358227 |
| 90 | MP0005390_skeleton_phenotype | 0.69010715 |
| 91 | MP0001905_abnormal_dopamine_level | 0.68866508 |
| 92 | MP0005174_abnormal_tail_pigmentation | 0.67989276 |
| 93 | MP0003091_abnormal_cell_migration | 0.67760883 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.67638473 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 0.66811150 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.66219367 |
| 97 | MP0005164_abnormal_response_to | 0.64430673 |
| 98 | MP0005389_reproductive_system_phenotype | 0.63056594 |
| 99 | MP0000249_abnormal_blood_vessel | 0.61897794 |
| 100 | MP0005076_abnormal_cell_differentiation | 0.61496192 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.60645794 |
| 102 | MP0003786_premature_aging | 0.60366590 |
| 103 | MP0003690_abnormal_glial_cell | 0.59453645 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 0.59178193 |
| 105 | MP0008961_abnormal_basal_metabolism | 0.58485124 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.57254555 |
| 107 | MP0000465_gastrointestinal_hemorrhage | 0.56872011 |
| 108 | MP0002693_abnormal_pancreas_physiology | 0.55244579 |
| 109 | MP0001851_eye_inflammation | 0.54561174 |
| 110 | MP0003252_abnormal_bile_duct | 0.53324939 |
| 111 | MP0001765_abnormal_ion_homeostasis | 0.53198376 |
| 112 | MP0001764_abnormal_homeostasis | 0.52613222 |
| 113 | MP0009840_abnormal_foam_cell | 0.52164894 |
| 114 | MP0003566_abnormal_cell_adhesion | 0.50190465 |
| 115 | MP0003828_pulmonary_edema | 0.49524806 |
| 116 | MP0001663_abnormal_digestive_system | 0.47996915 |
| 117 | MP0001968_abnormal_touch/_nociception | 0.47668783 |
| 118 | MP0002928_abnormal_bile_duct | 0.47552219 |
| 119 | MP0004742_abnormal_vestibular_system | 0.46542763 |
| 120 | MP0003795_abnormal_bone_structure | 0.45886515 |
| 121 | MP0000015_abnormal_ear_pigmentation | 0.45668039 |
| 122 | MP0004043_abnormal_pH_regulation | 0.45094396 |
| 123 | MP0002095_abnormal_skin_pigmentation | 0.44665551 |
| 124 | MP0005379_endocrine/exocrine_gland_phen | 0.43748382 |
| 125 | MP0000371_diluted_coat_color | 0.42864264 |
| 126 | MP0001881_abnormal_mammary_gland | 0.40662982 |
| 127 | MP0008873_increased_physiological_sensi | 0.39910666 |
| 128 | MP0001915_intracranial_hemorrhage | 0.39704707 |
| 129 | MP0002132_abnormal_respiratory_system | 0.38545021 |
| 130 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.37359856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.21971917 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.88359856 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.80210072 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.42371685 |
| 5 | Increased IgM level (HP:0003496) | 4.90873458 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 4.89545368 |
| 7 | Recurrent viral infections (HP:0004429) | 4.81520792 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.46876860 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.46436433 |
| 10 | Vasculitis (HP:0002633) | 4.44328847 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.39187971 |
| 12 | Chronic otitis media (HP:0000389) | 4.33852129 |
| 13 | Recurrent bronchitis (HP:0002837) | 4.25679949 |
| 14 | Agammaglobulinemia (HP:0004432) | 4.21335893 |
| 15 | Recurrent skin infections (HP:0001581) | 4.13338673 |
| 16 | Hypoproteinemia (HP:0003075) | 4.11587333 |
| 17 | Myositis (HP:0100614) | 4.07838744 |
| 18 | Abnormality of T cell number (HP:0011839) | 4.05774686 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.85798590 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.85798590 |
| 21 | Cellulitis (HP:0100658) | 3.85375601 |
| 22 | T lymphocytopenia (HP:0005403) | 3.80929235 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.80129365 |
| 24 | Basal ganglia calcification (HP:0002135) | 3.67658482 |
| 25 | Stomatitis (HP:0010280) | 3.65708117 |
| 26 | Meningitis (HP:0001287) | 3.62013756 |
| 27 | Hypergammaglobulinemia (HP:0010702) | 3.52785452 |
| 28 | Optic neuritis (HP:0100653) | 3.46697223 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 3.46697223 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 3.43069870 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.40317571 |
| 32 | Obstructive lung disease (HP:0006536) | 3.40317571 |
| 33 | Orchitis (HP:0100796) | 3.39853485 |
| 34 | Abnormality of T cells (HP:0002843) | 3.35517273 |
| 35 | Pustule (HP:0200039) | 3.25132740 |
| 36 | Gingivitis (HP:0000230) | 3.23323396 |
| 37 | Colitis (HP:0002583) | 3.23299392 |
| 38 | IgG deficiency (HP:0004315) | 3.18233536 |
| 39 | Nasal polyposis (HP:0100582) | 3.15461783 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 3.13311102 |
| 41 | Chronic sinusitis (HP:0011109) | 3.12004603 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.11183985 |
| 43 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.10787754 |
| 44 | Lymphopenia (HP:0001888) | 3.08761665 |
| 45 | Thyroiditis (HP:0100646) | 3.06214807 |
| 46 | Eosinophilia (HP:0001880) | 3.05850611 |
| 47 | Periodontitis (HP:0000704) | 3.04966028 |
| 48 | Gastrointestinal stroma tumor (HP:0100723) | 3.02013859 |
| 49 | Aplastic anemia (HP:0001915) | 3.00106967 |
| 50 | Recurrent pneumonia (HP:0006532) | 2.99419914 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.96833164 |
| 52 | Autoimmune hemolytic anemia (HP:0001890) | 2.95713599 |
| 53 | Panhypogammaglobulinemia (HP:0003139) | 2.94654098 |
| 54 | Leukocytosis (HP:0001974) | 2.93679824 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.89338116 |
| 56 | IgA deficiency (HP:0002720) | 2.87844439 |
| 57 | Abnormality of T cell physiology (HP:0011840) | 2.87609534 |
| 58 | Recurrent sinusitis (HP:0011108) | 2.86280557 |
| 59 | Gastrointestinal inflammation (HP:0004386) | 2.85070940 |
| 60 | Combined immunodeficiency (HP:0005387) | 2.83221531 |
| 61 | Recurrent lower respiratory tract infections (HP:0002783) | 2.82228863 |
| 62 | Hemiplegia (HP:0002301) | 2.80440307 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.78148178 |
| 64 | Severe combined immunodeficiency (HP:0004430) | 2.76358610 |
| 65 | Abnormality of eosinophils (HP:0001879) | 2.72472655 |
| 66 | IgM deficiency (HP:0002850) | 2.70589547 |
| 67 | Osteomyelitis (HP:0002754) | 2.70403998 |
| 68 | Abnormality of the nasal mucosa (HP:0000433) | 2.66643353 |
| 69 | Hemoptysis (HP:0002105) | 2.66272070 |
| 70 | Granulocytopenia (HP:0001913) | 2.60744544 |
| 71 | Thrombocytosis (HP:0001894) | 2.58114500 |
| 72 | Congenital stationary night blindness (HP:0007642) | 2.54202267 |
| 73 | Porencephaly (HP:0002132) | 2.49156124 |
| 74 | Emphysema (HP:0002097) | 2.47936466 |
| 75 | Pulmonary embolism (HP:0002204) | 2.46131962 |
| 76 | Petechiae (HP:0000967) | 2.42966794 |
| 77 | Arterial thrombosis (HP:0004420) | 2.42932453 |
| 78 | Vacuolated lymphocytes (HP:0001922) | 2.42677117 |
| 79 | Chronic diarrhea (HP:0002028) | 2.41110773 |
| 80 | Verrucae (HP:0200043) | 2.40742336 |
| 81 | Papilloma (HP:0012740) | 2.40742336 |
| 82 | Abnormality of B cell number (HP:0010975) | 2.40656600 |
| 83 | B lymphocytopenia (HP:0010976) | 2.40656600 |
| 84 | Sepsis (HP:0100806) | 2.40179181 |
| 85 | Hypochromic anemia (HP:0001931) | 2.37819379 |
| 86 | Gingival bleeding (HP:0000225) | 2.37253174 |
| 87 | Gangrene (HP:0100758) | 2.35930473 |
| 88 | Skin ulcer (HP:0200042) | 2.32605614 |
| 89 | Prostate neoplasm (HP:0100787) | 2.32342842 |
| 90 | Acute hepatic failure (HP:0006554) | 2.29834542 |
| 91 | Encephalitis (HP:0002383) | 2.29700460 |
| 92 | Hematochezia (HP:0002573) | 2.29355254 |
| 93 | Bronchitis (HP:0012387) | 2.28167430 |
| 94 | Urticaria (HP:0001025) | 2.26687790 |
| 95 | Chest pain (HP:0100749) | 2.25476298 |
| 96 | Joint swelling (HP:0001386) | 2.25334219 |
| 97 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.25185780 |
| 98 | Keratoconjunctivitis sicca (HP:0001097) | 2.24742108 |
| 99 | Abnormality of the pleura (HP:0002103) | 2.20256238 |
| 100 | Arthralgia (HP:0002829) | 2.18146515 |
| 101 | Stomach cancer (HP:0012126) | 2.15536608 |
| 102 | Spontaneous hematomas (HP:0007420) | 2.15020266 |
| 103 | Abnormality of the prostate (HP:0008775) | 2.14032169 |
| 104 | Increased IgE level (HP:0003212) | 2.13613150 |
| 105 | Thick nail (HP:0001805) | 2.13185922 |
| 106 | Hypochromic microcytic anemia (HP:0004840) | 2.12266437 |
| 107 | Poor head control (HP:0002421) | 2.11479378 |
| 108 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.11302379 |
| 109 | Lymphoma (HP:0002665) | 2.09147349 |
| 110 | Cleft eyelid (HP:0000625) | 2.05753178 |
| 111 | Hypoplasia of the thymus (HP:0000778) | 2.05203247 |
| 112 | Keratoconjunctivitis (HP:0001096) | 2.03873493 |
| 113 | Neutropenia (HP:0001875) | 2.02677706 |
| 114 | Hypoalbuminemia (HP:0003073) | 2.00855695 |
| 115 | Abnormal albumin level (HP:0012116) | 2.00855695 |
| 116 | Anorexia (HP:0002039) | 1.94161891 |
| 117 | Alveolar cell carcinoma (HP:0006519) | 1.93337386 |
| 118 | Epistaxis (HP:0000421) | 1.92849070 |
| 119 | Pancreatic cysts (HP:0001737) | 1.92028374 |
| 120 | 3-Methylglutaconic aciduria (HP:0003535) | 1.89723659 |
| 121 | Microcytic anemia (HP:0001935) | 1.89610730 |
| 122 | Polyneuropathy (HP:0001271) | 1.85251909 |
| 123 | Keratitis (HP:0000491) | 1.81256465 |
| 124 | Skin rash (HP:0000988) | 1.81087625 |
| 125 | Attenuation of retinal blood vessels (HP:0007843) | 1.80789176 |
| 126 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.77088561 |
| 127 | Recurrent otitis media (HP:0000403) | 1.76346232 |
| 128 | Ureteral stenosis (HP:0000071) | 1.73827694 |
| 129 | Ureteral obstruction (HP:0006000) | 1.72406221 |
| 130 | Prolonged bleeding time (HP:0003010) | 1.71185073 |
| 131 | Glomerulopathy (HP:0100820) | 1.70051125 |
| 132 | Abnormality of the renal cortex (HP:0011035) | 1.68856867 |
| 133 | Abnormality of male internal genitalia (HP:0000022) | 1.66577970 |
| 134 | Amyotrophic lateral sclerosis (HP:0007354) | 1.64688139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.39480614 |
| 2 | TYK2 | 4.11684865 |
| 3 | MAP4K1 | 3.72395243 |
| 4 | BLK | 3.32673280 |
| 5 | JAK3 | 3.31290098 |
| 6 | TBK1 | 3.27817259 |
| 7 | RIPK4 | 3.16869628 |
| 8 | IKBKE | 3.15973403 |
| 9 | IRAK4 | 3.05312973 |
| 10 | JAK1 | 2.81356426 |
| 11 | TXK | 2.77119035 |
| 12 | PBK | 2.76164838 |
| 13 | MAP3K13 | 2.49348473 |
| 14 | IKBKB | 2.18797863 |
| 15 | FGFR4 | 2.09100462 |
| 16 | KIT | 2.07458795 |
| 17 | SYK | 2.03329829 |
| 18 | FRK | 1.95798763 |
| 19 | ZAP70 | 1.90558157 |
| 20 | CSK | 1.77967867 |
| 21 | MST4 | 1.69550492 |
| 22 | MAP3K10 | 1.65970730 |
| 23 | ERN1 | 1.65205660 |
| 24 | FGFR3 | 1.65132616 |
| 25 | IRAK3 | 1.61449196 |
| 26 | STK10 | 1.57209966 |
| 27 | BTK | 1.56298791 |
| 28 | CAMKK2 | 1.54804440 |
| 29 | PIM2 | 1.53748856 |
| 30 | GRK6 | 1.47816198 |
| 31 | HCK | 1.38707671 |
| 32 | LCK | 1.38533025 |
| 33 | STK4 | 1.32016569 |
| 34 | LYN | 1.31289759 |
| 35 | CHUK | 1.30001197 |
| 36 | CSF1R | 1.29989560 |
| 37 | PIM1 | 1.24787239 |
| 38 | SIK3 | 1.23600415 |
| 39 | TEC | 1.16594702 |
| 40 | MARK3 | 1.14123890 |
| 41 | BMPR2 | 1.11062822 |
| 42 | ITK | 1.10208975 |
| 43 | NEK9 | 1.09027644 |
| 44 | ZAK | 1.08904073 |
| 45 | NUAK1 | 1.05758159 |
| 46 | RPS6KA4 | 1.02375170 |
| 47 | MAP3K11 | 1.00475713 |
| 48 | SIK2 | 0.96306753 |
| 49 | JAK2 | 0.95885866 |
| 50 | PRKCQ | 0.95418535 |
| 51 | LRRK2 | 0.93375557 |
| 52 | MATK | 0.87636638 |
| 53 | FES | 0.87216326 |
| 54 | NLK | 0.86942115 |
| 55 | PIK3CG | 0.86198514 |
| 56 | MAP2K6 | 0.84510398 |
| 57 | IRAK1 | 0.82001840 |
| 58 | MAPKAPK3 | 0.81070688 |
| 59 | TAOK3 | 0.79797497 |
| 60 | GRK1 | 0.78227567 |
| 61 | NME2 | 0.77962703 |
| 62 | EPHB1 | 0.77845951 |
| 63 | TYRO3 | 0.76887153 |
| 64 | BCKDK | 0.75574212 |
| 65 | EPHA3 | 0.75391274 |
| 66 | EIF2AK2 | 0.74727555 |
| 67 | CAMKK1 | 0.73968357 |
| 68 | ARAF | 0.69333796 |
| 69 | CDK12 | 0.69022438 |
| 70 | ACVR1B | 0.66685624 |
| 71 | TRPM7 | 0.66627368 |
| 72 | CLK1 | 0.64743089 |
| 73 | VRK1 | 0.61745714 |
| 74 | ADRBK1 | 0.60357281 |
| 75 | PIK3CA | 0.60071842 |
| 76 | PRKCD | 0.59113171 |
| 77 | WNK4 | 0.57381504 |
| 78 | IRAK2 | 0.55416955 |
| 79 | ABL1 | 0.53396031 |
| 80 | BMX | 0.53383178 |
| 81 | FGR | 0.51223114 |
| 82 | PASK | 0.50976885 |
| 83 | MAP3K5 | 0.50299929 |
| 84 | PINK1 | 0.49005625 |
| 85 | MUSK | 0.48931467 |
| 86 | CDK4 | 0.48228523 |
| 87 | GRK5 | 0.46710315 |
| 88 | BMPR1B | 0.43049096 |
| 89 | YES1 | 0.41172322 |
| 90 | EGFR | 0.38586118 |
| 91 | STK11 | 0.37325713 |
| 92 | PTK2B | 0.36080650 |
| 93 | CDK19 | 0.36031714 |
| 94 | OXSR1 | 0.34411074 |
| 95 | MAPK11 | 0.33655338 |
| 96 | ADRBK2 | 0.33391381 |
| 97 | MAPK13 | 0.33022426 |
| 98 | RPS6KA5 | 0.32779111 |
| 99 | MAPKAPK2 | 0.31455754 |
| 100 | TLK1 | 0.30949456 |
| 101 | TGFBR2 | 0.30737943 |
| 102 | PDK1 | 0.30464291 |
| 103 | FYN | 0.30272287 |
| 104 | KDR | 0.29553509 |
| 105 | ABL2 | 0.29345842 |
| 106 | FLT3 | 0.28670164 |
| 107 | INSR | 0.27829984 |
| 108 | DAPK2 | 0.27631650 |
| 109 | INSRR | 0.26945134 |
| 110 | TESK1 | 0.26508467 |
| 111 | PKN1 | 0.23568972 |
| 112 | EIF2AK1 | 0.23544559 |
| 113 | PAK3 | 0.23272972 |
| 114 | EIF2AK3 | 0.23047637 |
| 115 | HIPK2 | 0.22890912 |
| 116 | DYRK1B | 0.22707707 |
| 117 | ATR | 0.22534260 |
| 118 | PRKCH | 0.22133083 |
| 119 | GRK7 | 0.21670394 |
| 120 | MAP3K12 | 0.21097910 |
| 121 | MAP3K8 | 0.19844507 |
| 122 | MAPK4 | 0.19511075 |
| 123 | CDK3 | 0.18883900 |
| 124 | PRKCA | 0.18482816 |
| 125 | SGK2 | 0.18457544 |
| 126 | MAP4K2 | 0.18062499 |
| 127 | AKT3 | 0.17995705 |
| 128 | MAP3K7 | 0.17317577 |
| 129 | PRKACA | 0.16620976 |
| 130 | ALK | 0.15762961 |
| 131 | STK3 | 0.15746972 |
| 132 | CDK6 | 0.15437932 |
| 133 | TESK2 | 0.14820152 |
| 134 | MAPK3 | 0.14501869 |
| 135 | IGF1R | 0.13817136 |
| 136 | RPS6KA6 | 0.13783882 |
| 137 | TNK2 | 0.10834181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.56249940 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.46738382 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.34212755 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.09605058 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.00771479 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.89832157 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.84992355 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.82901101 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.73014802 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.72010315 |
| 11 | Influenza A_Homo sapiens_hsa05164 | 2.15921061 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.15009106 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.14937746 |
| 14 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.13233855 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.12205858 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12155437 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.05976909 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98707415 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.96603593 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.94950331 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.90675497 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.88279493 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.84978329 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.77700335 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.77616185 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.71220750 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.69815467 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.67292724 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65711815 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65375366 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55662814 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.54837545 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.54270991 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.52280654 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42396629 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.41158290 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.39655247 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.31773821 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.30570473 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29589096 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.25927485 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.16902460 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.13718245 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98944261 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 0.96978556 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 0.88910777 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88436795 |
| 48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88292997 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.86718646 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 0.84461723 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83600281 |
| 52 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83363229 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.80125152 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78482443 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75647385 |
| 56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72297882 |
| 57 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69069497 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66411136 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64132662 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62863978 |
| 61 | Proteasome_Homo sapiens_hsa03050 | 0.62275507 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61998590 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61968987 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60906254 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60840424 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.59894953 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57025474 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55679163 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54744954 |
| 70 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54534607 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54072240 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51620903 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50417065 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48684527 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.47613603 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46602266 |
| 77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46439469 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45330417 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44934277 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44502094 |
| 81 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.43806462 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42756248 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40630181 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39388313 |
| 85 | Morphine addiction_Homo sapiens_hsa05032 | 0.39220125 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.38401809 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38317974 |
| 88 | RNA polymerase_Homo sapiens_hsa03020 | 0.37593419 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.36754409 |
| 90 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34742128 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33217073 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31783871 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.31741488 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30628523 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30520254 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29421275 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.29172244 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28942426 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.28244828 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.27898482 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27690947 |
| 102 | RNA degradation_Homo sapiens_hsa03018 | 0.27581184 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27428096 |
| 104 | Base excision repair_Homo sapiens_hsa03410 | 0.25974242 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24696937 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23634302 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22099919 |
| 108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19640450 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.18901152 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.18473537 |
| 111 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.18244898 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.18167854 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.17974506 |
| 114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.14547748 |
| 115 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.14138521 |
| 116 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.13865766 |
| 117 | Taste transduction_Homo sapiens_hsa04742 | 0.11836616 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.11432660 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.11288870 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.11097288 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.10724343 |
| 122 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.10091577 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.09792061 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09613622 |
| 125 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.08768197 |
| 126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.08487025 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.07957048 |
| 128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.07657874 |
| 129 | DNA replication_Homo sapiens_hsa03030 | 0.07594613 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.06771362 |

